Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Authors: Shirish M. Gadgeel, Solange Peters, Tony Mok, Alice T. Shaw, D.W. Kim, Sai‐Hong Ignatius Ou, M. Pérol, Anna Wrona, Silvia Novello, Rafael Rosell, Ali Zeaiter, Tian Liu, Eveline Nüesch, Bogdan Balas, D. Ross Camidge - Annals of Oncology 2018 cited by 324